These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Renal haemodynamics after chronic treatment with labetalol and propranolol.
    Author: Malini PL, Strocchi E, Negroni S, Ambrosioni E, Magnani B.
    Journal: Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):123S-126S. PubMed ID: 7093095.
    Abstract:
    1 Effective renal plasma flow (ERPF) and glomerular filtration rate (GFR) were measured in two groups of 12 patients both at rest and during sub-maximal cycloergometer exercise while on placebo and after 3 months of treatment with either labetalol or propranolol. 2 ERPF increased and renal vascular resistance decreased both at rest and during exercise after labetalol treatment, compared with placebo; the opposite was observed after propranolol treatment. 3 GFR increased after labetalol and decreased after propranolol both at rest and during exercise, compared with placebo, but these changes were not statistically significant. 4 Labetalol and propranolol resulted in the same decrease in blood pressure and a comparable incidence of side effects.
    [Abstract] [Full Text] [Related] [New Search]